Clover Health Investments (NASDAQ:CLOV – Get Free Report) is projected to issue its quarterly earnings data before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $346.92 million for the quarter.
Clover Health Investments Stock Down 1.4 %
NASDAQ CLOV opened at $4.49 on Friday. The stock has a market cap of $2.25 billion, a PE ratio of -22.42 and a beta of 1.99. Clover Health Investments has a fifty-two week low of $0.61 and a fifty-two week high of $4.87. The business has a 50 day moving average price of $3.91 and a two-hundred day moving average price of $3.48.
Wall Street Analyst Weigh In
Separately, Craig Hallum assumed coverage on Clover Health Investments in a research report on Tuesday, December 17th. They set a “buy” rating and a $6.00 price target on the stock.
About Clover Health Investments
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
See Also
- Five stocks we like better than Clover Health Investments
- Growth Stocks: What They Are, Examples and How to Invest
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Most Volatile Stocks, What Investors Need to Know
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- How to Most Effectively Use the MarketBeat Earnings Screener
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.
